OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molnupiravir: Mechanism of action, clinical, and translational science
Brian M. Maas, Julie Strizki, Randy R. Miller, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 2
Open Access | Times Cited: 8
Brian M. Maas, Julie Strizki, Randy R. Miller, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 2
Open Access | Times Cited: 8
Showing 8 citing articles:
Pharmacokinetics and bioequivalence of a molnupiravir tablet formulation compared with the molnupiravir capsule formulation in healthy adult participants—a randomized, open-label, three-period, crossover study
Joseph Fiore, Yoon Jin, Tycho Heimbach, et al.
Antimicrobial Agents and Chemotherapy (2025)
Open Access
Joseph Fiore, Yoon Jin, Tycho Heimbach, et al.
Antimicrobial Agents and Chemotherapy (2025)
Open Access
Comparison of effectiveness and safety of molnupiravir versus sotrovimab for COVID‐19: A systematic review and meta‐analysis
Bahman Amani, Behnam Amani
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 1
Bahman Amani, Behnam Amani
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 1
Effective, but Safe? Physiologically Based Pharmacokinetic (PBPK)-Modeling-Based Dosing Study of Molnupiravir for Risk Assessment in Pediatric Subpopulations
Sarang Mishra, Katharina Rox
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 4112-4122
Closed Access
Sarang Mishra, Katharina Rox
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 4112-4122
Closed Access
Assessment of pharmacokinetics and tolerability following single‐dose administration of molnupiravir in participants with hepatic or renal impairment
Kelly Duncan, Russ P. Carstens, Kristin L. Butterfield, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 12
Open Access
Kelly Duncan, Russ P. Carstens, Kristin L. Butterfield, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 12
Open Access
Multidrug Combinations against SARS-CoV-2 Using GS-441524 or Ivermectin with Molnupiravir and/or Nirmatrelvir in Reconstituted Human Nasal Airway Epithelia
Denise Siegrist, Hulda R. Jónsdóttir, Mendy Bouveret, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1262-1262
Open Access
Denise Siegrist, Hulda R. Jónsdóttir, Mendy Bouveret, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1262-1262
Open Access
Analysis of COVID-19 patient outcomes with molnupiravir treatment and the role of risk factors: a single-centre retrospective descriptive study
Ondřej Zahornacký, Štefan Porubčin, Alena Rovňáková, et al.
Central European Journal of Public Health (2024) Vol. 32, Iss. Supplement, pp. 104-110
Closed Access
Ondřej Zahornacký, Štefan Porubčin, Alena Rovňáková, et al.
Central European Journal of Public Health (2024) Vol. 32, Iss. Supplement, pp. 104-110
Closed Access
Inhibition of hostN-myristoylation compromises the infectivity of SARS-CoV-2 due to Golgi-bypassing egress from lysosomes and endoplasmic reticulum
Saber H. Saber, Mohammed R. Shaker, Julian Sng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Saber H. Saber, Mohammed R. Shaker, Julian Sng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
